We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
African Pioneer Plc | LSE:ASP | London | Ordinary Share | IM00B8C0HK22 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.75 | 3.50 | 4.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
11/1/2009 19:01 | Well it looks like not many shareholders have held out which is surprising as this offer looks like a complete rip-off to me. I haven't accepted the offer, just hoping the approx 5% they need to reach the 90% required acceptances still do hold out. | mog | |
18/12/2008 09:16 | Has Christmas come early ? 28p is a bit cheaky even in these market conditions.Doing it over the Christmas / New year is rude. Shareholders should hold out. | condom2 | |
17/12/2008 09:22 | Having invested in this company 4 years before it came to AIM and at a period when it needed funds I feel very dissapointed that the directors are able to buy the company back for such a low price taking advantage of the present market climate for small stocks. | ltinvestor | |
17/12/2008 08:51 | indeed, internally the mgmt think the business is worth over 50p.. | chrisdgb | |
17/12/2008 08:30 | hmm...28p, bit lower than expected but in these times, not a shock | billyboychrisd | |
15/12/2008 16:59 | cheers, will take a look. | chrisdgb | |
15/12/2008 16:56 | Ecoanimal health EAH good divi and capital growth potential dyor | ltinvestor | |
15/12/2008 16:45 | you invested in anything else interesting at the moment it?? | chrisdgb | |
15/12/2008 16:02 | around 30p! | ltinvestor | |
15/12/2008 11:51 | anyone else have an idea of the bid price?? | chrisdgb | |
12/12/2008 10:37 | price tightening...bid by Christmas..??? add to my Macro 4 present already... | chrisdgb | |
11/12/2008 10:24 | i was trying to be cautious!! i think previous broker notes suggest at least 40p... | chrisdgb | |
11/12/2008 10:14 | The management are determined to buy the business because the future prospects are excellent and are not reflected in the share price even at 33p! | ltinvestor | |
11/12/2008 09:38 | article in FT saying ECI raised new funding, they are the bidder so looks good. agm yesterday confirmed takeover talks ongoing. 33/35p looks the level... | chrisdgb | |
21/11/2008 08:30 | Anybody expecting bid news soon? | deep powder | |
12/11/2008 11:41 | ECI Ventures supposed to be exclusive on the bid, wonder what the price will be, 33p????? | chrisdgb | |
03/10/2008 13:42 | nice to see Artemis buying... | chrisdgb | |
01/10/2008 08:02 | nice looking results this morning, should move through the 30p.... apparently management think company is worth 60p per share.... | chrisdgb | |
19/8/2008 17:49 | Any guesses to buyout price?I am holding on as I expect the price to be higher than todays price. | ltinvestor | |
12/6/2008 09:25 | Caution urged on EPS release two contracts 10 Jun 2008 Community pharmacists have been warned to take care when signing contracts for systems to support release two of the Electronic Prescription Service (EPS) as some pharmacies have been waiting more than two years for release one systems. The Pharmaceutical Services Negotiating Committee (PSNC) said it had been contacted by pharmacists who had signed up for a release one system from one supplier, Ascribe. Despite signing contracts with Ascribe more than two years ago the pharmacists were still waiting for the supplier to achieve Connecting for Health (CfH) compliance status. Latest information on the CfH website shows that seven commercially available pharmacy systems have achieved release one compliance with Ascribe yet to achieve technical accreditation. Graham Beck, pharmacy business manager for Ascribe, said Ascribe was working closely with CfH in achieving release one compliance and working towards EPS release two. He told EHI Primary Care: "The Ascribe Park System proved itself to be 'technically capable' of interaction with the N3 spine in 2007. Since then a number of clinical changes have been asked of us by the national programme which have created regrettable delays. The ETP software is in test with CfH and we expect accreditation to follow shortly. "Some of our customers did commit to buy the ETP compliant system two years ago, and development of the software commenced as a result of this commitment. Once again, we expect ETP accreditation to follow shortly." So far no pharmacy or GP system suppliers have achieved technical accreditation for release two of EPS. Lindsay McClure, head of information services at the PSNC, told EHI Primary Care: "Our advice is that if a pharmacy is signing up for release two that they should make sure there are appropriate break clauses in the contract if a supplier doesn't achieve compliance within a reasonable timeframe." The PSNC said contractors who had signed up for a release one system which had yet to be delivered, and who are members of the National Pharmacy Association, could obtain legal advice from the NPA. The initial implementation of release two of EPS was originally planned for October 2007 and in January CfH said it hoped initial implementation would begin in spring or summer 2008. CfH said the delay was due to system suppliers not being ready to test their systems in a live environment. | v6syncro | |
30/5/2008 16:28 | Ascribe's other 11 UK National Health Service contracts that it has won over 4 years had better be good! e-prescribing is a big play and for Ascribe not to be participating is bad. No doubt time will tell | v6syncro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions